Altered light-dark phase-dependent behavioral responses and suprachiasmatic nucleus pathology in an α-synuclein rat model of Parkinson’s disease

Read full text
Authors: Hanna Weber, Meike Statz, Nicolas Casadei, Olaf Riess, Franziska Richter, Wiebke Hermann, Alexander Storch, Mareike Fauser
Cited by: 1
References: 88

Abstract

Abstract Disruption of circadian rhythms is a key feature of neurodegenerative diseases and a non-motor feature of Parkinson’s disease, which significantly impairs health-related quality of life; yet, the underlying mechanisms are only partially understood. Preclinical animal models with neuropathological and symptomatic significance might contribute to a better understanding of circadian dysfunction. Here, we investigated light-dark phase-dependent modulation of motor and non-motor behavior as well as suprachiasmatic nucleus integrity in α -synuclein-overexpressing rats and wild-type controls. Behavioral testing in 3-month-old animals revealed robust phase-dependent modulation of exploratory activity, locomotion, sucrose preference, and olfaction-guided feeding in wild-type rats, which was absent in their transgenic littermates. Histological analyses demonstrated reduced overall cell density and pronounced α -synuclein accumulation in the suprachiasmatic nucleus of α -synuclein rats, accompanied by altered cellular composition, including altered neuronal, orexinergic, and microglial markers. α -synuclein load was positively correlated with Orexin A + fibers and Iba1 + cell counts, suggesting a link between protein aggregation, neuroinflammation, and altered light-dark phase-dependent behavior. These findings indicate that α -synuclein rats lack phase-dependent behavioral alternations and exhibit suprachiasmatic nucleus pathology already at an early disease stage with very mild motor impairment, providing a translational model to study different aspects of non-motor symptoms in Parkinson’s disease.

Fields of Study & Subjects

Parkinson's Disease Mechanisms and Treatments Circadian rhythm and melatonin Neurological disorders and treatments

Publication details

Journal / source
npj Parkinson s Disease
Publisher
Springer Science and Business Media LLC
Volume
12
Issue
1
Publication date
19 June 2026
Language
EN